Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Efficacy of GK530G in Acne Vulgaris
NCT01910064Phase 3Completed
- Sponsor
- Galderma
- Start
- May 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of adapalene, benzoyl peroxide in acne vulgaris, sponsored by Galderma. Started May 2013; status: completed.
02
Drugs
adapalenebenzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01910064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01910064.